AIM ImmunoTech Inc. — Form 8-K
Filed September 10, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 72/100
What the filing says
AIM ImmunoTech agreed to exchange a portion of a $3.301M promissory note (original principal dated November 18, 2025, from Streeterville Capital, LLC) for an unspecified number of common shares. The exchange agreement partitions an undisclosed amount from the original note, cancels that partitioned portion, and issues shares free-trading under Rule 144. Dollar amount of partition and share count are blank in the filed template.
Why this rating
Debt-for-equity swap of material size (~52% of $6.4M market cap if full note exchanged). Dilution, weakened balance sheet, and blank material terms create uncertainty. Negative for existing shareholders despite relieving cash pressure.
Price action (we called it negative)
before filing · preread $0.22 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from September 10, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.